Knight Therapeutics Inc.
KHTRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $504,120 | $552,032 | $591,199 | $654,583 |
| - Cash | $80,106 | $58,761 | $71,679 | $85,963 |
| + Debt | $49,459 | $69,091 | $77,700 | $40,958 |
| Enterprise Value | $473,473 | $562,362 | $597,220 | $609,578 |
| Revenue | $371,304 | $328,199 | $293,563 | $243,478 |
| % Growth | 13.1% | 11.8% | 20.6% | – |
| Gross Profit | $174,405 | $152,652 | $138,061 | $115,412 |
| % Margin | 47% | 46.5% | 47% | 47.4% |
| EBITDA | $64,384 | $40,897 | $25,261 | $42,593 |
| % Margin | 17.3% | 12.5% | 8.6% | 17.5% |
| Net Income | $4,332 | -$16,835 | -$29,892 | $15,675 |
| % Margin | 1.2% | -5.1% | -10.2% | 6.4% |
| EPS Diluted | 0.043 | -0.16 | -0.26 | 0.13 |
| % Growth | 126.8% | 38.5% | -300% | – |
| Operating Cash Flow | $36,280 | $35,939 | $40,481 | $44,618 |
| Capital Expenditures | -$31,472 | -$9,958 | -$25,816 | -$224,183 |
| Free Cash Flow | $4,808 | $25,981 | $14,665 | -$179,565 |